TTI-101
Drug Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | TTI-101 |
| Trade Name | |
| Synonyms | TTI101|TTI 101|C188-9 |
| Drug Descriptions |
TTI-101 (C188-9) is a small molecule that binds to STAT3 and inhibits signaling, potentially resulting in tumor cell death (PMID: 27027445, PMID: 32475130). |
| DrugClasses | STAT3 Inhibitor 26 |
| CAS Registry Number | 432001-19-9 |
| NCIT ID | C151932 |
Filtering
- Case insensitive filtering will display rows if any text in any cell matches the filter term
- Use simple literal full or partial string matches
- Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
- Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
- Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")
Sorting
- Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
- Click on any column header arrows to sort by that column
- Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Atezolizumab + Bevacizumab + TTI-101 | Atezolizumab Bevacizumab TTI-101 | 0 | 1 |
| Fulvestrant + TTI-101 | Fulvestrant TTI-101 | 0 | 1 |
| Palbociclib + TTI-101 | Palbociclib TTI-101 | 0 | 1 |
| Pembrolizumab + TTI-101 | Pembrolizumab TTI-101 | 0 | 1 |
| Ribociclib + TTI-101 | Ribociclib TTI-101 | 0 | 1 |
| TTI-101 | TTI-101 | 0 | 4 |
CKB BOOST